Left Atrial Appendage Closure Workshop
On Saturday morning February 18, Lankenau Heart Institute kicked off CRT’s live case 2017 broadcasts when cardiologists Sheetal Chandhok, MD, and William Gray, MD, Chief of the MLH Division of Cardiovascular Disease and President of the Lankenau Heart Institute, assisted by structural fellow Roi Altit, MD, performed a WATCHMAN™ Implant as part of a Left Atrial Appendage Closure workshop. The procedure, which offers patients with non-valvular atrial fibrillation an alternative to long-term warfarin medication for stroke prevention, also requires general anesthesia and TEE imaging, which was expertly provided by Sandra Abramson, MD, and Shalin Patel, MD. Lankenau Heart Institute is a leader in the use of the WATCHMAN, with Bryn Mawr Hospital’s Dr. Chandhok being the first to perform the percutaneous implant of the WATCHMAN device in Pennsylvania.
Drug Eluding Stent (DES) Bioabsorbable and Drug Coated Balloons (DCB) Technologies Session
On Monday morning February 20, Lankenau Heart Institute broadcast a second case with cardiologists Amid Khan, MD, and Dr. Gray, assisted by interventional fellow Marwan Badri, MD, successfully performing a complex lower extremity intervention in a patient with life-style limiting claudication with difficult anatomy using multiple access points.
The Lankenau Heart Institute is Main Line Health’s premier, comprehensive cardiovascular medicine and surgery program. The Lankenau Heart Institute brings together the clinical expertise of all four Main Line Health acute care hospitals and community cardiology practices to ensure that patients receive a level of quality, service, and experience that is unprecedented in the region. Through the system-wide coordination of services, the Lankenau Heart Institute delivers preventive, diagnostic, therapeutic, and rehabilitative cardiovascular services at each of our locations including Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital.
Lankenau Heart Institute continues to be a pioneer in the use of beating-heart techniques and robotic-assisted procedures for coronary artery revascularization, minimally invasive and transcatheter approaches for valve repair and replacement, and complex aortic surgeries. With our growing experience and focus on minimally invasive techniques, Lankenau Heart Institute has expanded participation in clinical trials year over year. Our physicians are frequently invited to participate in clinical/medical device trials, many of these designed to facilitate minimally invasive procedures/approaches.
With a collaborative team of expert consultative cardiologists, interventional cardiologists, electrophysiologists, cardiovascular surgeons and specially trained nurses and technologists, the Lankenau Heart Institute is dedicated to managing and treating patients with heart failure, aortic disease, coronary and peripheral vascular disease, heart rhythm disorders and valve disease. Our team of cardiologists and cardiac specialists provide patients and their families with expert cardiac care, close to home.